Insider Shareholders with Direct Ownership of Genelux Corp (GNLX)
This section provides a comprehensive overview of the insiders with direct ownership of Genelux Corp (GNLX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
GENELUX CORP Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 524,501 | 19,000 | 505,501 | 9 |
Aug 01, 2024
Added 7.25%
|
|
|
Thomas Zindrick
President and CEO |
192,084 | 22,664 | 171,872 | 6 |
Dec 18, 2024
Added 43.9%
|
|
Qian Zhang
Associate VP, Research |
6,000 | 0 | 139,333 | 1 |
Feb 17, 2023
Added 4.13%
|
|
Lourie S. Zak
Chief Financial Officer |
77,972 | 2,103 | 82,452 | 5 |
Dec 18, 2024
Added 33.56%
|
| 52,711 | 900 | 52,711 | 4 |
Aug 01, 2024
Added 42.86%
|
|
| 52,001 | 0 | 52,001 | 4 |
Aug 01, 2024
Added 43.19%
|
|
| 58,251 | 14,190 | 45,791 | 7 |
Dec 30, 2024
Reduced 7.03%
|
|
|
Joseph Cappello
VP, Pharmaceutical Development |
53,218 | 9,565 | 43,653 | 6 |
Dec 18, 2024
Added 39.92%
|
|
Sean Ryder
General Counsel |
55,106 | 15,824 | 41,388 | 9 |
Dec 18, 2024
Added 34.71%
|
|
Tony Yu
VP, Clinical Trial Operations |
87,718 | 197,849 | 39,869 | 24 |
Dec 18, 2024
Added 42.11%
|
|
Ralph Smalling
Head of Regulatory |
29,498 | 3,445 | 31,847 | 7 |
Dec 18, 2024
Added 32.77%
|
|
Caroline Jewett
Head of Quality |
24,755 | 5,476 | 16,174 | 5 |
Jun 24, 2024
Reduced 23.47%
|
|
Gabe Woodward
Director |
4,186 | 0 | 4,186 | 2 |
Feb 17, 2023
Added 19.28%
|
|
Doug Samuelson
Vice President, Finance |
3,600 | 1,297 | 2,303 | 2 |
Aug 18, 2023
Reduced 36.03%
|
| 0 | 32,167 | 0 | 1 |
Sep 19, 2023
Reduced 100.0%
|